Mercado de dispositivos de administración nasal: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00014905
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 215
Buy Now

Se espera que el mercado de dispositivos de administración nasal alcance los 95.676,62 millones de dólares en 2027, frente a los 58.502,18 millones de dólares de 2019. Se estima que el mercado crecerá con una tasa compuesta anual del 6,4 % de 2020 a 2027.

< p> 

La administración nasal de medicamentos es una de las rutas de administración de medicamentos preferidas entre los pacientes y los proveedores de atención médica. Esto se puede atribuir principalmente a la naturaleza no invasiva de esta vía de administración y a una mayor absorbibilidad del fármaco por vía nasal. Además, la vía nasal ofrece un entorno menos hostil para los fármacos en comparación con la vía gastrointestinal, permitiendo así una mejor absorción del fármaco. La fácil administración de estos medicamentos juega un papel crucial en la mejora del cumplimiento de las terapias farmacológicas entre los pacientes, lo que a su vez impulsa los resultados de los pacientes. Teniendo en cuenta estos factores, la preferencia por la administración nasal de medicamentos está aumentando entre los pacientes y los proveedores de atención médica. Al ser altamente vascularizada, la cavidad nasal mejora la absorción del fármaco, lo que resulta en una acción rápida. La Organización Mundial de la Salud (OMS) tiene directrices específicas para los fabricantes, que describen todos los requisitos necesarios para la adopción de nuevos dispositivos de administración nasal con un sistema de administración de un solo uso. Por tanto, la administración nasal de fármacos, a diferencia de otras vías de administración de fármacos, no requiere métodos estériles estrictos para administrar fármacos en el cuerpo. Por lo tanto, la alta preferencia por la administración nasal de medicamentos entre pacientes y proveedores de atención médica, debido a la creciente conciencia sobre sus beneficios, está impulsando el crecimiento del mercado.

Mercados regionales lucrativos para dispositivos de administración nasal

Perspectivas del mercado

Prevalencia creciente de enfermedades respiratorias y del sistema nervioso central

Los estudios iniciales de prueba de concepto que utilizan Los nuevos dispositivos nasales de administración de fármacos mostraron resultados prometedores en el tratamiento de enfermedades respiratorias, trastornos neurológicos y otros. Los dispositivos de administración de fármacos desempeñan un papel esencial a la hora de garantizar la entrega de todo el fármaco al sitio objetivo de la cavidad nasal. En las últimas décadas, se han introducido varios enfoques innovadores de administración de fármacos que podrían superar los desafíos que implica cruzar la barrera hematoencefálica (BHE). Varios estudios científicos respaldan la especulación de que la administración de medicamentos por vía nasal puede permitir que concentraciones más altas de medicamentos atraviesen la BHE. La creciente incidencia de trastornos neurológicos aumentaría la demanda de dispositivos de administración nasal. Según la Sociedad Estadounidense de Oncología Clínica (ASCO), en 2020, se diagnosticaron ~3540 tumores cerebrales y otros tumores del SNC en niños pertenecientes al grupo de edad de 0 a 14 años en los EE. UU. El informe también indicó que el cerebro y otros tumores del SNC son los segundos cánceres más comunes entre los niños y representan ~26% de los casos de cáncer en niños

Los lanzamientos y aprobaciones de productos son estrategias comúnmente adoptadas por las empresas para expandir su presencia global y carteras de productos para satisfacer la creciente demanda de los consumidores. Los actores del mercado de dispositivos de administración nasal adoptan la estrategia de colaboración para ampliar la base de clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial.

Mercado de dispositivos de administración nasal - ndash; Por tipo de fármaco

  • Anestésicos
  • Antibióticos
  • Medicamentos para aliviar el dolor
  • Suplementos de calcio
  • Vasoconstrictores< /li>
  • Antihistamínicos
  • Otros

Mercado de dispositivos de administración nasal - ndash; Por tecnologías de administración

  • Spray
  • Nebulizadores
  • Inhaladores
  • Otros

Nasal Mercado de dispositivos de entrega: Por usuario final

  • Configuraciones de atención domiciliaria
  • Hospitales
  • Clínicas

Mercado de dispositivos de administración nasal: ndash; por Geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y Asia África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de Medio Oriente y África África
  • América del Sur y Central
    • Brasil
    • Argentina
    • Resto de América del Sur

Perfiles de empresas

  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc
  • BD
  • Sanofi
  • Merck & Co., Inc.
  • Cadila Pharmaceuticals Ltd.
  • Novartis AG
  • Dr. Laboratorios Reddy
  • Neurelis, Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are nasal delivery devices? What are the benefits?

Nasal drug delivery is one of the efficient route of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza amongst others. Moreover, nasal route is also suitable for the treatment of drug addiction as well as for sedation.

What are the driving factors for the nasal delivery devices market across the globe?

The factors that are driving growth of the market are growing prevalence of respiratory and cns diseases and increasing preference and awareness of intranasal drug delivery among patients.Moreover, strategic activities by the manufacturersare offering lucrative opportunities for the growth of the market.

Who are the major players in the nasal delivery devices market?

The nasal delivery devices market majorly consists of the players such as GlaxoSmithKline plc.,AstraZeneca, Pfizer Inc., BD, Sanofi, Merck & Co., Inc., Cadila Pharmaceuticals Ltd., Novartis AG, Dr. Reddy's Laboratories, and Neurelis. amongst others.

The List of Companies - Nasal delivery devices Market

  1. GlaxoSmithKline plc.
  2. AstraZeneca
  3. Pfizer Inc.
  4. BD
  5. Sanofi
  6. Merck & Co., Inc.
  7. Cadila Pharmaceuticals Ltd.
  8. Novartis AG
  9. Dr. Reddy's Laboratories
  10. Neurelis, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports